Germline pathogenic variants (GPV, including likely pathogenic variants) in BAP1 have subsequently been associated with a variety of tumours resulting in the recognition of BAP1-associated tumour predisposition syndrome (BAP1-TPDS) [2, 3]. Here, BAP1 is linked to BAP1-related tumor predisposition syndrome.